BIO-Europe Spring 2019 March 25th – 27th 2019 Messe Wien Exhibition and Congress Center, Vienna, Austria Invectys will be attending the BIO-Europe Spring 2019.…
Invectys will be attending the AACR Annual Meeting 2019, March 29 – Apr 3, 2019. Georgia World Congress Center Atlanta, The AACR (American Association for…
Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL Financing complements the…
January 7 – 10, 2019 J.P. Morgan 37th Annual Healthcare Conference 2019 San-Francisco The annual J.P. Morgan Healthcare Conference is the largest and most…
Invectys announces FDA approval to launch a Phase II clinical trial of its therapeutic cancer vaccine INVAC-1 After a recent capital raise of 4.3 M€s another…
After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines Paris, July 12th, 2017 – This round brings…
Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…
Invectys will attend to the 18th annual BIO€QUITY Europe Meet Invectys there ! More information: invest@invectys.com 18TH ANNUAL BIO€QUITY EUROPE Bio€quity…
